Amyloidosis and device therapy: an open debate

Egle Corrado, Salvatore Novo, Eluisa La Franca, Gianfranco Ciaramitaro, Giuseppe Coppola, Giuseppe Inga

Risultato della ricerca: Article

Abstract

Cardiac involvement represents a critical prognostic factor inamyloidosis, as it represents a leading cause of morbidity and mortality,in primary light chain amyloidosis, in hereditary and alsoin wild-type transthyretin amyloidosis. A 54-year-old male wasadmitted to Emergency Room with complaints of dyspnea, palpitationsand diaphoresis.
Lingua originaleEnglish
pagine (da-a)497-498
Numero di pagine2
RivistaINTERNATIONAL ANGIOLOGY
Stato di pubblicazionePublished - 2017

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Fingerprint Entra nei temi di ricerca di 'Amyloidosis and device therapy: an open debate'. Insieme formano una fingerprint unica.

  • Cita questo

    Corrado, E., Novo, S., La Franca, E., Ciaramitaro, G., Coppola, G., & Inga, G. (2017). Amyloidosis and device therapy: an open debate. INTERNATIONAL ANGIOLOGY, 497-498.